Chemokine Receptor Type 4 Interaction [EPC]

Chemokine Receptor Type 4 Interaction [EPC] was reported 1361 times

Drugs of the Chemokine Receptor Type 4 Interaction [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 RADIOTHERAPY TO TONGUE 1 1.0000
1 SEZARY CELLS INCREASED 2 0.2500
2 CUTANEOUS T-CELL LYMPHOMA RECURRENT 5 0.0794
3 LYMPHODEPLETION 2 0.0588
4 AUTOIMMUNE VASCULITIS 1 0.0588
5 PHOTOPHERESIS 1 0.0556
6 PSEUDOMONAL SKIN INFECTION 1 0.0417
7 LISTERAEMIA 1 0.0400
8 IMMUNOLOGY TEST 1 0.0370
9 THERAPY NAIVE 4 0.0323
10 HISTOPLASMOSIS CUTANEOUS 1 0.0208
11 CYTOMEGALOVIRUS ENTERITIS 7 0.0197
12 TERTIARY ADRENAL INSUFFICIENCY 1 0.0185
13 CD8 LYMPHOCYTES INCREASED 1 0.0161
14 OESOPHAGITIS CHEMICAL 1 0.0149
15 PLAGUE 1 0.0149
16 ERYTHEMA ANNULARE 4 0.0138
17 RASH PAPULOSQUAMOUS 2 0.0132
18 AUTOIMMUNE DERMATITIS 2 0.0132
19 ANAL FUNGAL INFECTION 1 0.0120
20 BULBAR PALSY 3 0.0108
21 EOSINOPHILIC PUSTULAR FOLLICULITIS 1 0.0108
22 ALPHA TUMOUR NECROSIS FACTOR INCREASED 1 0.0108
23 TUMOUR FLARE 7 0.0102
24 BENIGN LYMPH NODE NEOPLASM 1 0.0102
25 CUTANEOUS LYMPHOMA 2 0.0098
26 POIKILODERMA 1 0.0093
27 AUTOIMMUNE THYROID DISORDER 1 0.0092
28 CYTOMEGALOVIRUS ENTEROCOLITIS 7 0.0091
29 NODULAR RASH 2 0.0090
30 LISTERIA ENCEPHALITIS 1 0.0088
31 PNEUMOCOCCAL INFECTION 5 0.0084
32 LYMPHOMA TRANSFORMATION 3 0.0083
33 ACHROMOBACTER INFECTION 1 0.0083
34 SUPERFICIAL INFLAMMATORY DERMATOSIS 1 0.0081
35 INFECTED NEOPLASM 2 0.0080
36 PELVIC DEFORMITY 1 0.0078
37 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
38 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
39 CUTANEOUS T-CELL LYMPHOMA 9 0.0071
40 PERINEAL ULCERATION 1 0.0071
41 ENGRAFT FAILURE 2 0.0070
42 ABDOMINAL WALL WOUND 1 0.0065
43 GASTROENTERITIS STAPHYLOCOCCAL 1 0.0064
44 TUMOUR INVASION 3 0.0062
45 ALOPECIA TOTALIS 2 0.0061
46 SEPTIC ENCEPHALOPATHY 1 0.0058
47 BLOOD LACTIC ACID DECREASED 1 0.0058
48 VITILIGO 13 0.0055
49 ALOPECIA SCARRING 1 0.0055
50 CYTOMEGALOVIRUS OESOPHAGITIS 2 0.0054
51 T-LYMPHOCYTE COUNT INCREASED 1 0.0054
52 MYCOTIC ENDOPHTHALMITIS 1 0.0053
53 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0053
54 KERATITIS FUNGAL 1 0.0048
55 THYROXINE ABNORMAL 1 0.0047
56 DRUG ERUPTION 81 0.0046
57 AUTOIMMUNE NEPHRITIS 1 0.0045
58 HERPES ZOSTER CUTANEOUS DISSEMINATED 1 0.0043
59 TUMOUR ULCERATION 1 0.0042
60 GRANULOMATOUS DERMATITIS 1 0.0041
61 ICHTHYOSIS 1 0.0040
62 CHRONIC DISEASE 1 0.0039
63 BACTERIAL ENDOPHTHALMITIS 1 0.0038
64 INTERLEUKIN LEVEL INCREASED 2 0.0036
65 ACUTE POLYNEUROPATHY 1 0.0035
66 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
67 ALOPECIA UNIVERSALIS 1 0.0034
68 ENGRAFTMENT SYNDROME 2 0.0034
69 EAR INFECTION FUNGAL 1 0.0033
70 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 7 0.0033
71 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 1 0.0032
72 VACCINE INTERACTION 1 0.0032
73 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 1 0.0032
74 GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0032
75 RESPIRATORY MUSCLE WEAKNESS 1 0.0031
76 RESPIRATORY ALKALOSIS 5 0.0031
77 GRAFT VERSUS HOST DISEASE 22 0.0031
78 ACUTE HEPATITIS B 1 0.0030
79 ECTROPION 1 0.0030
80 URETERAL STENT INSERTION 1 0.0029
81 ALOPECIA AREATA 5 0.0028
82 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 4 0.0028
83 SPINAL CORD OEDEMA 1 0.0027
84 AORTIC RUPTURE 1 0.0026
85 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
86 HUMIDITY INTOLERANCE 1 0.0025
87 ECTHYMA 1 0.0025
88 SQUAMOUS CELL CARCINOMA OF THE TONGUE 1 0.0024
89 GRANULOMA SKIN 2 0.0024
90 LICHENIFICATION 1 0.0024
91 LYMPHOPENIA 34 0.0024
92 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
93 GLUCOCORTICOID DEFICIENCY 1 0.0024
94 TISSUE INJURY 1 0.0023
95 POSTRENAL FAILURE 1 0.0023
96 OSTOMY BAG PLACEMENT 1 0.0022
97 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
98 ECZEMA HERPETICUM 1 0.0022
99 AUTOIMMUNE HEPATITIS 15 0.0022
100 CYSTOID MACULAR OEDEMA 4 0.0021
101 AUTOIMMUNE MYOSITIS 1 0.0021
102 LENTIGO 1 0.0020
103 MENINGITIS LISTERIA 1 0.0020
104 DERMATITIS PSORIASIFORM 4 0.0020
105 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
106 MOLLUSCUM CONTAGIOSUM 1 0.0019
107 HYPEREOSINOPHILIC SYNDROME 1 0.0018
108 LUNG CONSOLIDATION 5 0.0018
109 GLOMERULONEPHRITIS MEMBRANOUS 2 0.0017
110 RECTAL ADENOCARCINOMA 1 0.0017
111 GLOMERULONEPHRITIS 4 0.0016
112 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
113 MEDICAL DEVICE SITE INFECTION 1 0.0016
114 MUSCLE ABSCESS 1 0.0016
115 DRY GANGRENE 1 0.0016
116 STAPHYLOCOCCAL ABSCESS 1 0.0016
117 AUTOIMMUNE COLITIS 1 0.0016
118 MYELOPROLIFERATIVE NEOPLASM 1 0.0015
119 EMERGENCY CARE EXAMINATION 1 0.0015
120 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
121 BILIARY TRACT DISORDER 2 0.0014
122 CRYOGLOBULINAEMIA 1 0.0014
123 VASCULITIS NECROTISING 1 0.0014
124 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
125 MYOCARDITIS 16 0.0014
126 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
127 NASAL INJURY 1 0.0014
128 BACTERIAL DISEASE CARRIER 1 0.0014
129 INFUSION SITE REACTION 4 0.0013
130 MICTURITION FREQUENCY DECREASED 1 0.0013
131 MIXED LIVER INJURY 4 0.0013
132 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
133 NEOPLASM SKIN 2 0.0013
134 PULMONARY MYCOSIS 1 0.0013
135 MYOPERICARDITIS 1 0.0013
136 SKIN NEOPLASM EXCISION 1 0.0013
137 HEPATITIS E 2 0.0013
138 SUPERINFECTION BACTERIAL 1 0.0013
139 HYPOPYON 1 0.0012
140 STARVATION 1 0.0012
141 COVID-19 IMMUNISATION 1 0.0012
142 SYSTEMIC CANDIDA 3 0.0012
143 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
144 GRANULOMA 4 0.0012
145 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
146 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
147 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
148 SKIN WEEPING 4 0.0011
149 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
150 MYOSITIS 10 0.0011
151 PROTEIN URINE 1 0.0011
152 SINUS NODE DYSFUNCTION 2 0.0011
153 C-REACTIVE PROTEIN 1 0.0011
154 LUPUS NEPHRITIS 2 0.0011
155 AUTOIMMUNE THYROIDITIS 4 0.0011
156 DISEASE PROGRESSION 123 0.0010
157 THERAPY PARTIAL RESPONDER 16 0.0010
158 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
159 OESOPHAGEAL CANDIDIASIS 4 0.0010
160 RENAL HAEMORRHAGE 2 0.0010
161 ANAPHYLACTOID REACTION 4 0.0010
162 DIVERTICULAR PERFORATION 2 0.0010
163 SKIN PLAQUE 8 0.0009
164 TUMOUR NECROSIS 1 0.0009
165 NAIL GROWTH ABNORMAL 1 0.0009
166 SUSPECTED COVID-19 3 0.0009
167 TUMOUR LYSIS SYNDROME 8 0.0009
168 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
169 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
170 ACUTE PULMONARY OEDEMA 5 0.0009
171 INFUSION RELATED REACTION 59 0.0009
172 ARTERIAL HAEMORRHAGE 1 0.0009
173 LICHENOID KERATOSIS 2 0.0009
174 PHOBIA 1 0.0009
175 MYASTHENIA GRAVIS 7 0.0009
176 RADIATION SKIN INJURY 1 0.0009
177 HEPATIC CYTOLYSIS 11 0.0009
178 LICHEN PLANUS 2 0.0009
179 RALES 5 0.0009
180 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
181 RECTAL ULCER 1 0.0009
182 FULL BLOOD COUNT INCREASED 1 0.0008
183 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
184 ENCEPHALITIS VIRAL 1 0.0008
185 IMMUNE-MEDIATED ENTEROCOLITIS 3 0.0008
186 ORAL MUCOSA EROSION 1 0.0008
187 SKIN DISORDER 27 0.0008
188 XEROSIS 1 0.0008
189 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
190 NOCARDIOSIS 2 0.0008
191 BLOOD BILIRUBIN ABNORMAL 1 0.0008
192 ANGINA UNSTABLE 5 0.0008
193 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
194 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1 0.0007
195 MUCOUS MEMBRANE DISORDER 1 0.0007
196 SKIN LESION 20 0.0007
197 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
198 VIRAEMIA 1 0.0007
199 NAIL INFECTION 1 0.0007
200 TOXIC SKIN ERUPTION 7 0.0007
201 ADENOVIRUS INFECTION 2 0.0007
202 STRESS CARDIOMYOPATHY 4 0.0007
203 CHOLANGIOCARCINOMA 1 0.0007
204 INFECTIOUS PLEURAL EFFUSION 1 0.0007
205 PNEUMONIA PSEUDOMONAL 1 0.0007
206 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
207 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
208 OPHTHALMOPLEGIA 1 0.0006
209 TINEA PEDIS 1 0.0006
210 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
211 NIGHT BLINDNESS 1 0.0006
212 STUPOR 2 0.0006
213 CRYPTOCOCCOSIS 1 0.0006
214 LYMPHOCYTE COUNT INCREASED 2 0.0006
215 IGA NEPHROPATHY 1 0.0006
216 NEPHRITIS 2 0.0006
217 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
218 COVID-19 PNEUMONIA 7 0.0006
219 TYMPANIC MEMBRANE PERFORATION 1 0.0006
220 EXPOSURE TO SARS-COV-2 1 0.0006
221 GLIOBLASTOMA 1 0.0006
222 NEPHROTIC SYNDROME 4 0.0006
223 RETINITIS 1 0.0006
224 SKIN NECROSIS 3 0.0006
225 PSEUDOMONAL SEPSIS 1 0.0006
226 POLYARTHRITIS 3 0.0006
227 HYPERCALCAEMIA 7 0.0006
228 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
229 SKIN HYPOPIGMENTATION 1 0.0006
230 POLYMYOSITIS 1 0.0006
231 PARAPARESIS 1 0.0006
232 CONJUNCTIVAL HYPERAEMIA 2 0.0006
233 AORTIC VALVE STENOSIS 1 0.0006
234 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
235 OPPORTUNISTIC INFECTION 1 0.0005
236 VITRITIS 1 0.0005
237 STEVENS-JOHNSON SYNDROME 12 0.0005
238 LYMPH NODE PAIN 1 0.0005
239 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
240 SKIN TOXICITY 3 0.0005
241 INTERVERTEBRAL DISCITIS 1 0.0005
242 PEMPHIGOID 4 0.0005
243 ADVERSE REACTION 7 0.0005
244 HYPOPROTEINAEMIA 1 0.0005
245 TONGUE OEDEMA 2 0.0005
246 RADIOTHERAPY 1 0.0005
247 NEOPLASM 6 0.0005
248 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
249 PROCEDURAL HAEMORRHAGE 2 0.0005
250 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
251 BRADYKINESIA 3 0.0005
252 CARDIAC DISCOMFORT 1 0.0005
253 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
254 CAPILLARY LEAK SYNDROME 1 0.0005
255 SKIN INDURATION 1 0.0005
256 CARDIOMYOPATHY 7 0.0005
257 VASCULAR OCCLUSION 1 0.0005
258 EAR SWELLING 1 0.0005
259 TEARFULNESS 2 0.0005
260 EXOPHTHALMOS 1 0.0005
261 HERPES SIMPLEX 3 0.0005
262 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
263 CORNEAL DISORDER 1 0.0005
264 CLOSTRIDIUM TEST POSITIVE 1 0.0005
265 DANDRUFF 1 0.0005
266 SKIN MASS 3 0.0004
267 BRAIN NEOPLASM MALIGNANT 2 0.0004
268 RASH 193 0.0004
269 PERIARTHRITIS 1 0.0004
270 IMMUNE THROMBOCYTOPENIA 2 0.0004
271 ERYTHEMA MULTIFORME 4 0.0004
272 PHOTOSENSITIVITY REACTION 7 0.0004
273 VARICELLA 1 0.0004
274 CHOLESTASIS 8 0.0004
275 THROMBOTIC MICROANGIOPATHY 4 0.0004
276 AUTOIMMUNE DISORDER 4 0.0004
277 HYPOPHOSPHATAEMIA 3 0.0004
278 STAPHYLOCOCCAL SEPSIS 2 0.0004
279 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
280 CORONARY ARTERY STENOSIS 2 0.0004
281 PLATELET DISORDER 1 0.0004
282 HAEMORRHAGE URINARY TRACT 1 0.0004
283 CANCER PAIN 1 0.0004
284 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
285 LUNG OPACITY 1 0.0004
286 RADICULOPATHY 1 0.0004
287 THERAPY NON-RESPONDER 17 0.0004
288 SKIN DISCOMFORT 1 0.0004
289 TACHYPNOEA 5 0.0004
290 LYMPHADENOPATHY 13 0.0004
291 ULCERATIVE KERATITIS 1 0.0004
292 RHINALGIA 1 0.0004
293 HYPERKERATOSIS 2 0.0004
294 CYTOMEGALOVIRUS INFECTION 6 0.0004
295 EOSINOPHIL COUNT INCREASED 3 0.0004
296 THERAPEUTIC RESPONSE DELAYED 1 0.0004
297 SKIN INFECTION 4 0.0004
298 SKIN HYPERTROPHY 1 0.0004
299 GENERALISED ERYTHEMA 2 0.0004
300 TUMOUR HAEMORRHAGE 1 0.0004
301 CHILLS 41 0.0003
302 PARAPLEGIA 1 0.0003
303 ENTEROCOLITIS 2 0.0003
304 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
305 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
306 DERMATITIS 7 0.0003
307 OROPHARYNGEAL DISCOMFORT 3 0.0003
308 HEPATITIS CHOLESTATIC 2 0.0003
309 MYELOFIBROSIS 1 0.0003
310 ADRENAL INSUFFICIENCY 4 0.0003
311 SEPTIC SHOCK 14 0.0003
312 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
313 BLOOD BLISTER 1 0.0003
314 HEPATITIS B REACTIVATION 1 0.0003
315 POLYMYALGIA RHEUMATICA 1 0.0003
316 RASH PAPULAR 7 0.0003
317 SKIN EROSION 1 0.0003
318 BACTERIAL SEPSIS 1 0.0003
319 THERAPY CHANGE 3 0.0003
320 OTITIS MEDIA 1 0.0003
321 INABILITY TO AFFORD MEDICATION 3 0.0003
322 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
323 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
324 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
325 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
326 BK VIRUS INFECTION 1 0.0003
327 SKIN EXFOLIATION 25 0.0003
328 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
329 B-CELL LYMPHOMA 1 0.0003
330 SUDDEN CARDIAC DEATH 1 0.0003
331 INTERSTITIAL LUNG DISEASE 14 0.0003
332 HYPERTRANSAMINASAEMIA 2 0.0003
333 ERYTHEMA NODOSUM 1 0.0003
334 PULMONARY TOXICITY 2 0.0003
335 HAEMORRHAGIC DIATHESIS 1 0.0003
336 CUTANEOUS VASCULITIS 1 0.0003
337 HEPATITIS 7 0.0003
338 SENSITIVE SKIN 2 0.0003
339 TRANSAMINASES INCREASED 6 0.0003
340 RETINOPATHY 1 0.0003
341 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
342 CATHETER SITE INFECTION 1 0.0003
343 TROPONIN INCREASED 2 0.0003
344 PAIN OF SKIN 7 0.0003
345 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
346 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
347 RASH MACULAR 9 0.0003
348 EJECTION FRACTION DECREASED 4 0.0003
349 PNEUMONITIS 7 0.0003
350 PNEUMONIA FUNGAL 1 0.0003
351 BACTERAEMIA 3 0.0003
352 SEPSIS 28 0.0003
353 RASH ERYTHEMATOUS 12 0.0003
354 BLEPHARITIS 1 0.0002
355 ORGAN FAILURE 1 0.0002
356 FUNGAL SKIN INFECTION 1 0.0002
357 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
358 CYTOPENIA 3 0.0002
359 GASTROINTESTINAL PERFORATION 1 0.0002
360 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
361 ONYCHOMADESIS 1 0.0002
362 POOR PERIPHERAL CIRCULATION 1 0.0002
363 DRUG RESISTANCE 6 0.0002
364 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
365 SKIN HYPERPIGMENTATION 2 0.0002
366 NAIL DISORDER 2 0.0002
367 LYMPHOCYTE COUNT DECREASED 4 0.0002
368 UVEITIS 3 0.0002
369 HYPOTHYROIDISM 7 0.0002
370 EAR DISORDER 1 0.0002
371 IRON DEFICIENCY ANAEMIA 2 0.0002
372 MASS 3 0.0002
373 ROSACEA 1 0.0002
374 PERFORMANCE STATUS DECREASED 1 0.0002
375 BLISTER 12 0.0002
376 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
377 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
378 HYPOVOLAEMIC SHOCK 1 0.0002
379 SUBCUTANEOUS ABSCESS 1 0.0002
380 GUILLAIN-BARRE SYNDROME 1 0.0002
381 PANCREATIC DISORDER 1 0.0002
382 HOSPICE CARE 2 0.0002
383 HYPERNATRAEMIA 1 0.0002
384 CYTOKINE RELEASE SYNDROME 4 0.0002
385 ERYSIPELAS 1 0.0002
386 HYPOXIA 7 0.0002
387 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
388 SLUGGISHNESS 2 0.0002
389 FEMORAL NECK FRACTURE 1 0.0002
390 TEMPERATURE INTOLERANCE 2 0.0002
391 FOLLICULITIS 2 0.0002
392 SUDDEN DEATH 2 0.0002
393 COLITIS 7 0.0002
394 THERAPY INTERRUPTED 13 0.0002
395 ANAPHYLACTIC REACTION 10 0.0002
396 INFECTION 26 0.0002
397 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
398 INTESTINAL PERFORATION 2 0.0002
399 REBOUND EFFECT 2 0.0002
400 PRURITUS 68 0.0002
401 PERONEAL NERVE PALSY 1 0.0002
402 NEUTROPHILIA 1 0.0002
403 MYOCARDIAL ISCHAEMIA 2 0.0002
404 SCAB 2 0.0002
405 ERYTHEMA 36 0.0002
406 SKIN ATROPHY 1 0.0002
407 BLOOD URIC ACID INCREASED 1 0.0002
408 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
409 SKIN WARM 1 0.0002
410 EOSINOPHILIA 3 0.0002
411 HYPERTRIGLYCERIDAEMIA 1 0.0002
412 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
413 ENERGY INCREASED 1 0.0002
414 DISEASE RECURRENCE 8 0.0002
415 ODYNOPHAGIA 1 0.0002
416 HEPATITIS B 1 0.0002
417 C-REACTIVE PROTEIN INCREASED 6 0.0002
418 DERMATITIS ACNEIFORM 1 0.0002
419 CONJUNCTIVITIS 3 0.0002
420 GENERALISED OEDEMA 2 0.0002
421 BACTERIAL INFECTION 3 0.0002
422 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
423 SWELLING OF EYELID 1 0.0002
424 HYPOCALCAEMIA 3 0.0002
425 THERAPEUTIC RESPONSE CHANGED 1 0.0002
426 METABOLIC ACIDOSIS 5 0.0002
427 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
428 MUCOSAL INFLAMMATION 4 0.0002
429 ASPERGILLUS INFECTION 1 0.0002
430 HYPOGAMMAGLOBULINAEMIA 1 0.0002
431 IMMUNE SYSTEM DISORDER 2 0.0002
432 WALKING AID USER 1 0.0002
433 PANCREATITIS 8 0.0002
434 APPETITE DISORDER 1 0.0002
435 PYREXIA 52 0.0002
436 CARDIAC FAILURE ACUTE 1 0.0001
437 FUNGAL INFECTION 5 0.0001
438 RASH PRURITIC 8 0.0001
439 ONYCHOCLASIS 1 0.0001
440 LARGE INTESTINE POLYP 1 0.0001
441 RHABDOMYOLYSIS 6 0.0001
442 BLOOD TEST ABNORMAL 2 0.0001
443 SKIN REACTION 2 0.0001
444 PAPULE 1 0.0001
445 METASTASIS 1 0.0001
446 HYPERSOMNIA 4 0.0001
447 TONGUE DISORDER 1 0.0001
448 HYPERTHYROIDISM 2 0.0001
449 ALOPECIA 27 0.0001
450 APATHY 2 0.0001
451 MELAENA 3 0.0001
452 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
453 LIVER DISORDER 6 0.0001
454 CEREBRAL DISORDER 1 0.0001
455 ARTHROPOD BITE 1 0.0001
456 RASH MACULO-PAPULAR 3 0.0001
457 FEELING DRUNK 1 0.0001
458 PULMONARY MASS 2 0.0001
459 IMMUNODEFICIENCY 2 0.0001
460 THROMBOCYTOPENIA 15 0.0001
461 SUNBURN 1 0.0001
462 HEPATIC FAILURE 4 0.0001
463 LIPASE INCREASED 1 0.0001
464 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
465 FOOD ALLERGY 1 0.0001
466 TENDONITIS 2 0.0001
467 OEDEMA 7 0.0001
468 HYPOALBUMINAEMIA 1 0.0001
469 PULMONARY HAEMORRHAGE 1 0.0001
470 DRUG-INDUCED LIVER INJURY 4 0.0001
471 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
472 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
473 RENAL CYST 1 0.0001
474 PRODUCTIVE COUGH 6 0.0001
475 PANCYTOPENIA 7 0.0001
476 BLOOD DISORDER 1 0.0001
477 ACUTE KIDNEY INJURY 19 0.0001
478 DECUBITUS ULCER 1 0.0001
479 HICCUPS 1 0.0001
480 STAPHYLOCOCCAL INFECTION 4 0.0001
481 FEBRILE NEUTROPENIA 8 0.0001
482 AGEUSIA 3 0.0001
483 INFUSION SITE ERYTHEMA 1 0.0001
484 PSEUDOMONAS INFECTION 1 0.0001
485 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
486 BLOOD MAGNESIUM DECREASED 1 0.0001
487 SKIN SWELLING 1 0.0001
488 RESPIRATORY TRACT INFECTION 3 0.0001
489 ECZEMA 6 0.0001
490 BLOOD CALCIUM INCREASED 1 0.0001
491 GASTRITIS 3 0.0001
492 SPINAL OSTEOARTHRITIS 1 0.0001
493 LUNG INFILTRATION 1 0.0001
494 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
495 EAR INFECTION 3 0.0001
496 FACIAL PAIN 1 0.0001
497 COLITIS ULCERATIVE 5 0.0001
498 HAEMOLYTIC ANAEMIA 1 0.0001
499 ANAL INCONTINENCE 1 0.0001
500 LEUKOCYTOSIS 2 0.0001
501 LIP DRY 1 0.0001
502 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
503 ADVERSE EVENT 10 0.0001
504 RHINORRHOEA 7 0.0001
505 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
506 HEPATIC FUNCTION ABNORMAL 4 0.0001
507 NEPHROPATHY 1 0.0001
508 HEPATIC CIRRHOSIS 2 0.0001
509 SQUAMOUS CELL CARCINOMA 1 0.0001
510 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
511 ACUTE RESPIRATORY FAILURE 2 0.0001
512 EAR PAIN 2 0.0001
513 SKIN FISSURES 2 0.0001
514 NASAL CONGESTION 6 0.0001
515 CONDITION AGGRAVATED 31 0.0001
516 KNEE OPERATION 1 0.0001
517 BODY TEMPERATURE DECREASED 1 0.0001
518 LEUKOPENIA 5 0.0001
519 BONE MARROW FAILURE 2 0.0001
520 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
521 POOR VENOUS ACCESS 1 0.0001
522 RESPIRATORY FAILURE 7 0.0001
523 PETECHIAE 1 0.0001
524 WEIGHT FLUCTUATION 1 0.0001
525 MUSCULOSKELETAL PAIN 5 0.0001
526 RENAL IMPAIRMENT 8 0.0001
527 SCRATCH 1 0.0001
528 NEUROPATHY PERIPHERAL 9 0.0001
529 CYSTITIS 3 0.0001
530 SKIN CANCER 2 0.0001
531 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
532 SWELLING FACE 6 0.0001
533 SKIN LACERATION 1 0.0001
534 OSTEONECROSIS 3 0.0001
535 ANGIOEDEMA 4 0.0001
536 VISUAL ACUITY REDUCED 3 0.0001
537 VENTRICULAR FIBRILLATION 1 0.0001
538 MALNUTRITION 1 0.0001
539 ORAL PAIN 2 0.0001
540 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
541 MYALGIA 15 0.0001
542 HEPATIC ENZYME INCREASED 6 0.0001
543 SKIN DISCOLOURATION 4 0.0001
544 SHOCK 2 0.0001
545 MADAROSIS 1 0.0001
546 RENAL DISORDER 4 0.0001
547 VASCULITIS 1 0.0001
548 HYPERKALAEMIA 3 0.0001
549 COVID-19 15 0.0001
550 ATAXIA 1 0.0001
551 PRODUCT PRESCRIBING ERROR 2 0.0001
552 CHOLECYSTITIS 1 0.0001
553 MYOCLONUS 1 0.0001
554 MYELOSUPPRESSION 3 0.0001
555 DRY SKIN 11 0.0001
556 NOCTURIA 1 0.0001
557 LIVER INJURY 2 0.0001
558 ENCEPHALOPATHY 2 0.0001
559 MUSCLE SPASTICITY 1 0.0001
560 TENDON RUPTURE 1 0.0001
561 PNEUMONIA ASPIRATION 2 0.0001
562 DERMATITIS ALLERGIC 1 0.0001
563 ANAEMIA 15 0.0001
564 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
565 INFLAMMATION 4 0.0001
566 SKIN ULCER 2 0.0001
567 DIPLOPIA 2 0.0001
568 PLATELET COUNT INCREASED 1 0.0001
569 NODULE 1 0.0001
570 BLOOD CREATININE INCREASED 5 0.0001
571 DEAFNESS 2 0.0001
572 ORAL CANDIDIASIS 1 0.0001
573 PULMONARY CONGESTION 1 0.0001
574 SOPOR 1 0.0001
575 QUALITY OF LIFE DECREASED 1 0.0001
576 SINUS CONGESTION 1 0.0001
577 PALLOR 2 0.0001
578 DIVERTICULITIS 2 0.0001
579 FEELING COLD 2 0.0001
580 APHONIA 1 0.0001
581 SLEEP DISORDER 5 0.0001
582 HEPATOCELLULAR INJURY 1 0.0001
583 CARDIOGENIC SHOCK 1 0.0001
584 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
585 LABORATORY TEST ABNORMAL 2 0.0001
586 SKIN HAEMORRHAGE 1 0.0001
587 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
588 ADVERSE DRUG REACTION 6 0.0001
589 NEUTROPENIA 9 0.0001
590 EPILEPSY 2 0.0001
591 INSURANCE ISSUE 1 0.0001
592 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
593 HOSPITALISATION 10 0.0001
594 DEVICE RELATED INFECTION 1 0.0001
595 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
596 THYROID DISORDER 1 0.0001
597 HYPOTENSION 13 0.0001
598 LYMPHOMA 1 0.0001
599 ACUTE MYELOID LEUKAEMIA 1 0.0001
600 DEATH 55 0.0001
601 FATIGUE 49 0.0001
602 ULCER 1 0.0001
603 SENSORY DISTURBANCE 1 0.0001
604 CARDIAC FAILURE 5 0.0001
605 NIGHT SWEATS 2 0.0001
606 MUSCLE TIGHTNESS 1 0.0001
607 BLOOD POTASSIUM INCREASED 1 0.0001
608 DEEP VEIN THROMBOSIS 4 0.0001
609 RENAL FAILURE 8 0.0001
610 VIRAL INFECTION 2 0.0001
611 CIRCULATORY COLLAPSE 1 0.0001
612 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
613 NEOPLASM PROGRESSION 2 0.0001
614 ORTHOSTATIC HYPOTENSION 1 0.0001
615 MALAISE 25 0.0001
616 HEART RATE DECREASED 2 0.0001
617 DEPRESSED MOOD 3 0.0001
618 COLD SWEAT 1 0.0001
619 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
620 TACHYCARDIA 5 0.0001
621 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
622 ISCHAEMIC STROKE 1 0.0001
623 THIRST 1 0.0001
624 OSTEOMYELITIS 1 0.0001
625 HYPERGLYCAEMIA 2 0.0001
626 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
627 PRODUCT DOSE OMISSION ISSUE 16 0.0001
628 DYSURIA 2 0.0001
629 THINKING ABNORMAL 1 0.0001
630 OXYGEN SATURATION DECREASED 3 0.0001
631 TOXICITY TO VARIOUS AGENTS 9 0.0001
632 MUSCULAR WEAKNESS 6 0.0001
633 BLOOD URINE PRESENT 1 0.0001
634 PULMONARY EMBOLISM 5 0.0001
635 HERPES ZOSTER 3 0.0001
636 CONTUSION 5 0.0001
637 DECREASED APPETITE 12 0.0001
638 ORAL HERPES 1 0.0001
639 PARAESTHESIA 8 0.0001
640 WHEEZING 3 0.0001
641 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
642 SOMNOLENCE 10 0.0000
643 DIARRHOEA 32 0.0000
644 STOMATITIS 3 0.0000
645 ILL-DEFINED DISORDER 3 0.0000
646 FEEDING DISORDER 1 0.0000
647 DRY MOUTH 4 0.0000
648 VERTIGO 3 0.0000
649 FLUSHING 5 0.0000
650 BODY TEMPERATURE INCREASED 1 0.0000
651 LUNG NEOPLASM MALIGNANT 2 0.0000
652 ILLNESS 5 0.0000
653 CARDIO-RESPIRATORY ARREST 2 0.0000
654 MOUTH ULCERATION 1 0.0000
655 PLATELET COUNT DECREASED 5 0.0000
656 LIVER FUNCTION TEST INCREASED 1 0.0000
657 POOR QUALITY SLEEP 1 0.0000
658 PRURITUS GENERALISED 1 0.0000
659 PSORIASIS 6 0.0000
660 HEPATOTOXICITY 1 0.0000
661 PANCREATITIS ACUTE 1 0.0000
662 HYPOKALAEMIA 2 0.0000
663 PNEUMONIA 14 0.0000
664 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
665 NAUSEA 34 0.0000
666 COGNITIVE DISORDER 2 0.0000
667 BURNING SENSATION 3 0.0000
668 CARDIAC DISORDER 4 0.0000
669 DYSPNOEA 24 0.0000
670 OCULAR HYPERAEMIA 2 0.0000
671 DYSPHAGIA 4 0.0000
672 SKIN BURNING SENSATION 3 0.0000
673 MOBILITY DECREASED 3 0.0000
674 HEPATIC CANCER 1 0.0000
675 PRESYNCOPE 1 0.0000
676 ATRIAL FIBRILLATION 4 0.0000
677 LUNG DISORDER 2 0.0000
678 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
679 SYNCOPE 4 0.0000
680 CELLULITIS 2 0.0000
681 GASTRIC CANCER 1 0.0000
682 DIABETES MELLITUS 3 0.0000
683 BLOOD PRESSURE INCREASED 6 0.0000
684 THERAPY CESSATION 2 0.0000
685 ERECTILE DYSFUNCTION 1 0.0000
686 ANAPHYLACTIC SHOCK 1 0.0000
687 UNRESPONSIVE TO STIMULI 1 0.0000
688 RASH GENERALISED 1 0.0000
689 ARTHRITIS 3 0.0000
690 DRUG INTERACTION 6 0.0000
691 CHEST PAIN 7 0.0000
692 HYPERSENSITIVITY 7 0.0000
693 OFF LABEL USE 33 0.0000
694 DEHYDRATION 5 0.0000
695 ASTHENIA 14 0.0000
696 BLOOD BILIRUBIN INCREASED 1 0.0000
697 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
698 LIMB INJURY 1 0.0000
699 TREMOR 6 0.0000
700 PROCEDURAL PAIN 1 0.0000
701 ARTHROPATHY 2 0.0000
702 DEMENTIA 1 0.0000
703 WEIGHT INCREASED 8 0.0000
704 INTENTIONAL DOSE OMISSION 1 0.0000
705 ANGINA PECTORIS 1 0.0000
706 LETHARGY 2 0.0000
707 BALANCE DISORDER 3 0.0000
708 BACK PAIN 8 0.0000
709 DYSPHONIA 2 0.0000
710 BLADDER CANCER 2 0.0000
711 RESPIRATORY DISORDER 1 0.0000
712 EMOTIONAL DISTRESS 4 0.0000
713 PERIPHERAL SWELLING 5 0.0000
714 FEMUR FRACTURE 1 0.0000
715 COUGH 9 0.0000
716 VOMITING 15 0.0000
717 MOOD SWINGS 1 0.0000
718 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
719 BLOOD PRESSURE DECREASED 2 0.0000
720 LIP SWELLING 1 0.0000
721 URINARY RETENTION 1 0.0000
722 NEOPLASM MALIGNANT 2 0.0000
723 CHEST DISCOMFORT 3 0.0000
724 GASTRIC DISORDER 1 0.0000
725 NIGHTMARE 1 0.0000
726 DELIRIUM 1 0.0000
727 ABDOMINAL DISTENSION 3 0.0000
728 DRUG INEFFECTIVE 37 0.0000
729 CEREBRAL HAEMORRHAGE 1 0.0000
730 CRYING 1 0.0000
731 CONSTIPATION 6 0.0000
732 PANIC ATTACK 1 0.0000
733 PAIN IN EXTREMITY 8 0.0000
734 HEADACHE 17 0.0000
735 EYE SWELLING 1 0.0000
736 DYSPNOEA EXERTIONAL 1 0.0000
737 HOT FLUSH 2 0.0000
738 ARTHRALGIA 11 0.0000
739 ACNE 2 0.0000
740 ABNORMAL BEHAVIOUR 1 0.0000
741 FEELING ABNORMAL 6 0.0000
742 CARDIAC FAILURE CONGESTIVE 2 0.0000
743 THROMBOSIS 2 0.0000
744 OEDEMA PERIPHERAL 3 0.0000
745 PAIN 15 0.0000
746 TREATMENT FAILURE 2 0.0000
747 DIZZINESS 12 0.0000
748 HYPERTENSION 5 0.0000
749 LOSS OF CONSCIOUSNESS 3 0.0000
750 MENTAL DISORDER 1 0.0000
751 PULMONARY OEDEMA 1 0.0000
752 SKIN IRRITATION 1 0.0000
753 NEPHROLITHIASIS 1 0.0000
754 MUSCLE SPASMS 4 0.0000
755 TINNITUS 1 0.0000
756 SWELLING 2 0.0000
757 ARRHYTHMIA 1 0.0000
758 FALL 7 0.0000
759 DRUG INTOLERANCE 2 0.0000
760 HYPOAESTHESIA 3 0.0000
761 FLUID RETENTION 1 0.0000
762 HAEMOGLOBIN DECREASED 2 0.0000
763 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
764 NERVOUSNESS 1 0.0000
765 SPEECH DISORDER 1 0.0000
766 INSOMNIA 5 0.0000
767 HAEMATOCHEZIA 1 0.0000
768 WEIGHT DECREASED 5 0.0000
769 URTICARIA 3 0.0000
770 HYPONATRAEMIA 1 0.0000
771 EYE PAIN 1 0.0000
772 RHEUMATOID ARTHRITIS 2 0.0000
773 URINARY TRACT INFECTION 3 0.0000
774 BONE PAIN 1 0.0000
775 SURGERY 1 0.0000
776 CATARACT 1 0.0000
777 JOINT SWELLING 2 0.0000
778 PLEURAL EFFUSION 1 0.0000
779 DISCOMFORT 1 0.0000
780 FEELING HOT 1 0.0000
781 GAIT DISTURBANCE 3 0.0000
782 HYPERHIDROSIS 2 0.0000
783 PRODUCT DOSE OMISSION 1 0.0000
784 VISION BLURRED 2 0.0000
785 INJURY 1 0.0000
786 ANXIETY 4 0.0000
787 DYSGEUSIA 1 0.0000
788 UNEVALUABLE EVENT 1 0.0000
789 CHRONIC KIDNEY DISEASE 1 0.0000
790 CARDIAC ARREST 1 0.0000
791 DRUG ABUSE 1 0.0000
792 CEREBROVASCULAR ACCIDENT 2 0.0000
793 MYOCARDIAL INFARCTION 2 0.0000
794 INTENTIONAL PRODUCT MISUSE 1 0.0000
795 MUSCULOSKELETAL STIFFNESS 1 0.0000
796 GASTROINTESTINAL DISORDER 1 0.0000
797 NO ADVERSE EVENT 2 0.0000
798 SUICIDAL IDEATION 1 0.0000
799 OROPHARYNGEAL PAIN 1 0.0000
800 MIGRAINE 1 0.0000
801 SINUSITIS 1 0.0000
802 ABDOMINAL PAIN UPPER 2 0.0000
803 DEPRESSION 2 0.0000
804 ABDOMINAL PAIN 2 0.0000
805 PALPITATIONS 1 0.0000
806 MEMORY IMPAIRMENT 1 0.0000
807 CONFUSIONAL STATE 1 0.0000
808 ABDOMINAL DISCOMFORT 1 0.0000
809 NASOPHARYNGITIS 1 0.0000
810 PRODUCT USE ISSUE 1 0.0000
811 INCORRECT DOSE ADMINISTERED 1 0.0000